Factors associated with haemoglobin concentration among Timor-Leste children aged 6-59 months

K E Agho1, M J Dibley, C D'Este

  • 1School of Medicine, University of Western Sydney, NSW, Australia. k.agho@uws.edu.au

Insights

Anaemia prevalence is high in Timor-Leste children under two years old. Factors like recent diarrhoea, wasting, and maternal anaemia significantly impact children's haemoglobin levels, requiring targeted interventions.

Area of Science:

  • Public Health
  • Pediatrics
  • Nutritional Science

Background:

  • Anaemia is a significant global health issue affecting children.
  • Understanding the prevalence and associated factors of anaemia is crucial for effective public health interventions in Timor-Leste.

Purpose of the Study:

  • To assess the prevalence of haemoglobin (Hb) concentrations in children aged 6-59 months in Timor-Leste.
  • To identify factors associated with Hb concentrations in this population.

Main Methods:

  • Utilized data from the 2003 Timor-Leste Demographic and Health Survey, a multi-stage cluster survey.
  • Included 4,514 children aged 6-59 months in the analysis.
  • Employed backward stepwise hierarchical multiple regression to identify associated factors.

Main Results:

  • Overall anaemia prevalence was 38.2% in children aged 6-23 months and 22.6% in older children.
  • Factors associated with lower Hb concentrations included wasting, male sex, recent diarrhoea, higher household wealth (richest and middle-class), maternal education (some secondary or more, some primary), and maternal anaemia.
  • Increased child age and longer breastfeeding duration (6 months) were associated with higher Hb concentrations.

Conclusions:

  • Anaemia prevention programs in Timor-Leste should prioritize children under two years, those with recent diarrhoea, wasted children, children from higher socioeconomic status households, and children of anaemic mothers.

Related Concept Videos

Factors Affecting Respiration01:24

Factors Affecting Respiration

Respiration is a crucial physiological function involving exchanging oxygen (O2) and carbon dioxide (CO2) between an organism and its environment. Various factors can impact this essential process:
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Hemoglobin01:24

Hemoglobin

Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...